Galecto, Inc. received a deficiency letter from Nasdaq stating that it was not in compliance with the minimum $1.00 per share required for continued listing on The Nasdaq Global Select Market.
AI Assistant
DAMORA THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.